Share

    


In This Section

Companies A-Z

Search for Assistance Programs

Coherus BioSciences, Inc.

Oncology-related products:  

  • UDENYCA® (pegfilgrastim-cbqv) 

  • LOQTORZI® (toripalimab-tpzi) 

Coherus offers Coherus Solutions™ for patients prescribed UDENYCA and LOQTORZI. Coherus Solutions™ provides comprehensive patient support services to assist with access. 

Please feel free to contact Coherus Solutions™ at 1-844-483-3692 with any questions. Hours of operation are 8:00 AM – 8:00 PM CT Monday through Friday. 

For additional information please visit CoherusSolutions.com 

To register or log in to your Coherus Solutions™ account please visit https://portal.coherussolutions.com/login  

Patient Support Services Overview 

Enrollment support provided by Case Managers 

  • Product-specific benefit verification 

  • Co-pay enrollment 

  • Coverage, coding, and reimbursement support 

  • Appeals assistance 

Patient support through customized programs 

The Coherus Solutions™ Co-Pay Savings Program 

This program may reduce out-of-pockets costs for commercially insured eligible* patients.  

Eligible* patients may pay: 

  • As little as $0 out-of-pocket for each dose of UDENYCA  

  • As little as $0 out-of-pocket for each dose of LOQTORZI  

Covered costs may include co-pay, coinsurance and deductibles for the drug. Program does not cover costs associated with drug administration. The co-pay program has a 180-day lookback period. 

To enroll your patient, please go to CoherusSolutions.com and login 

*Eligibility Criteria 

  • Have commercial (private or non-governmental) health insurance that covers the medication costs of UDENYCA or LOQTORZI 

  • Be a U.S. resident 

  • Not covered by any federal, state, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, Veterans Affairs, Department of Defense, or TRICARE 

  • Not seek reimbursement from any third-party, including payers, charitable foundations, or flexible spending account (FSAs) or healthcare savings accounts (HSAs) for all or any part of the benefit received by Coherus through this program 

  • Other restrictions apply. Please see full terms and conditions: 

  • It is not available for cash paying patients or where prohibited by law 

  • Coherus Solutions Co-Pay Savings Program subject to change or discontinuation without notice. This is not health insurance. 

The LOQTORZI Solutions™ Patient Assistance Program 

Patients receiving LOQTORZI with no insurance or who are underinsured*, or with traditional Medicare fee-for-service (FFS) that demonstrate financial hardship and cannot afford their cost-sharing obligation may be eligible for patient assistance through the Patient Assistance Program (PAP). Patients with other government insurance, including Medicare Advantage, Medicare Part D, Fee-for-service Medicaid, Managed Medicaid, Veterans Affairs, Department of Defense, TRICARE, or any other insurance that is federally or state-funded are not eligible for Patient Assistance. 

*Underinsured means the patient does not have coverage for LOQTORZI. 

To enroll your patient, please go to CoherusSolutions.com and login 

Patient Eligibility Criteria 

  • Be either: (a) uninsured; (b) underinsured*; or (c) traditional Medicare FFS insured patient(s) that demonstrate financial hardship and cannot afford their cost-sharing obligation 

  • Have an adjusted annual household income of ≤ 500% of Federal Poverty Level (FPL) 

  • Complete and sign consent form and, when applicable, provide income documentation 

  • Be under the care of a U.S. licensed provider, and receive LOQTORZI in an established practice located in the U.S. incident to the prescribing physician’s professional services in the outpatient setting 

  • Be a U.S. resident of any U.S. state 

  • Diagnosis and dosing are consistent with FDA-approved indication for LOQTORZI, or provider believes LOQTORZI is medically necessary based on the patient’s diagnosis 

  • Not have any other financial support options 

  • The patient must receive the drug in an outpatient setting by the physician or physician office 

  • Providers requesting more than six (6) PAP fills for the same patient will be required to provide written attestation on business letterhead reaffirming continued PAP necessity (DX, patient therapy log, etc.) 

Independent Foundation Support 

Coherus Solutions™ may also be able to help your patients find financial support through charitable foundations. Case Managers can research alternative coverage options for your patients. 

Access support provided by Field Reimbursement Managers (FRMs) 

  • Billing, coding, & coverage overview 

  • Reimbursement health check 

  • Electronic Data Interchange (EDI) billing support 

  • Operations/workflow best practices for Coherus products 

  • Biosimilar reimbursement methodology 

  • Coherus Solutions™ services review 

  • Claim and PA denial & appeal support 

Please feel free to contact Coherus Solutions™ at 1-844-483-3692 with any questions. Hours of operation are 8:00 AM – 8:00 PM CT Monday through Friday. 

For additional information please visit CoherusSolutions.com 

 

US-CMB-0051  07/24 

Oncology-related products: Loqtorzi® (toripalimab-tpzil) injection, Udenyca® (pegfilgrastim-cbqv) injection

Reimbursement Assistance

Coherus Complete™

Reimbursement support provided by patient access specialists, include:

  • Product-specific benefit verification

  • Coverage, coding, and reimbursement

  • Prior authorization services

  • Product replacement support.

For reimbursement assistance, contact your field reimbursement manager (coheruscomplete.com) or call 1.844.483.3692, Monday through Friday, 8:00 AM to 8:00 PM EST.

Co-Pay Card/Out-Of-Pocket Cost Assistance

Coherus Complete™ Co-Pay Assistance Program

Coherus Complete offers a co-pay assistance program that covers out-of-pocket expenses related to Udenyca for commercially insured patients. Eligible patients qualify for $0 out-of-pocket costs for each Udenyca dose. The program has a 180-day lookback period. The maximum annual benefit is $15,000 per enrollment period. No physical co-pay card is required.

To be eligible for the Co-Pay Assistance Program, patients:

  • Must be prescribed Udenyca for a medically appropriate use

  • Must have commercial health insurance that covers the medication costs of Udenyca

  • Must not be covered by any federal-, state-, or government-funded healthcare program, such as Medicare, Medicaid, Medicare Advantage, Medicare Part D, Veterans Affairs, Department of Defense, or TriCare

  • Must not seek reimbursement amount received from Coherus from any third-party payers, including flexible spending accounts or healthcare savings accounts.

To enroll, go online.

For assistance with co-pay claims reimbursement, call the program at 1.844.483.3692, Monday through Friday, 8:00 AM to 8:00 PM EST.

The co-pay program only covers the costs of Udenyca and does not cover any administration or office visit costs. Restrictions may apply and not valid where prohibited by law. Coherus may revise or terminate this program without notice at any time.

Patient Assistance Program

Coherus Complete™ Patient Assistance Program

Patients with no insurance may be eligible for financial support for Udenyca through the patient assistance program. Patient eligibility criteria:

  • Uninsured, functionally underinsured, or Medicare patients that demonstrate financial hardship and cannot afford their cost-sharing obligation

  • Must meet all eligibility requirements to qualify

  • United States resident and must physically reside in the U.S. or U.S. territory

  • Be under the care of a U.S. licensed provider with an established practice located in the U.S.

  • Do not have any other financial support options

  • Diagnosis and dosing must be consistent with FDA-approved prescribing information for Udenyca

  • Adjusted annual household income of less than or equal to 500 percent of federal poverty level

  • Must receive treatment in an outpatient setting by the physician or physician office.

Underinsured includes patients with health insurance that does not cover an pegfilgrastim product (biosimilar or reference product).

Healthcare providers requesting more than six refills by the program for the same patient will be required to provide written attestation on business letterhead affirming continued program necessity.

If a patient received Udenyxa within the past six months, they may be eligible for retro patient assistance.

To enroll, fax the completed enrollment form to 1.877.226.3670.

For more information, visit the program website or call 1.844.483.3692, Monday through Friday, 8:00 AM to 8:00 PM EST.

Independent Charitable Foundations/Organizations

Coherus Complete™ Referrals

Coherus Complete may also be able to help patients find financial support through charitable foundations. Patient access specialists can research alternative coverage options for patients. When funding becomes available, the healthcare providers' practice will receive email notifications alerting them to available funds from charitable foundations. Patients must be enrolled in Coherus Complete.

To enroll, fax the completed enrollment form to 1.877.226.3670.

For more information, visit the program website or call 1.844.483.3692, Monday through Friday, 8:00 AM to 8:00 PM EST.